These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 971192)

  • 1. The effects of chronic mescaline administration on operant behavior in the pigeon.
    Hadorn D; Mandell AJ; Segal DS
    Behav Biol; 1976 Jul; 17(3):403-9. PubMed ID: 971192
    [No Abstract]   [Full Text] [Related]  

  • 2. Action of a chronic administration of mescaline in dynamic behavioural situations.
    Fundaro' A; Molinengo L; Cassone MC; Orsetti M
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(1):41-8. PubMed ID: 3704173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental influences upon drug-induced suppression of operant behavior.
    Sparber SB; Tilson HA
    J Pharmacol Exp Ther; 1971 Oct; 179(1):1-9. PubMed ID: 5096565
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological and behavioral components of tolerance to LSD and mescaline in rats.
    Murray TF; Craigmill AL; Fischer GJ
    Pharmacol Biochem Behav; 1977 Sep; 7(3):239-44. PubMed ID: 928480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone potentiates the disruptive effects of mescaline on operant responding in the rat.
    Commissaris RL; Moore KE; Rech RH
    Pharmacol Biochem Behav; 1980 Oct; 13(4):601-3. PubMed ID: 7433492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hallucinogens as discriminative stimuli.
    Winter JC
    Fed Proc; 1974 Jul; 33(7):1825-32. PubMed ID: 4209212
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of narcotics and narcotic antagonists on operant behavior.
    McMillan DE
    Adv Biochem Psychopharmacol; 1973; 8(0):345-59. PubMed ID: 4604406
    [No Abstract]   [Full Text] [Related]  

  • 8. Excitatory and inhibitory effects of mescaline on shuttle avoidance in the rat.
    Bridger WH; Mandel IJ
    Biol Psychiatry; 1971; 3(4):379-85. PubMed ID: 5163821
    [No Abstract]   [Full Text] [Related]  

  • 9. Stimulus properties of mescaline and N-methylated derivatives: difference in peripheral and direct central administration.
    Browne RG; Harris RT; Ho BT
    Psychopharmacologia; 1974; 39(1):43-56. PubMed ID: 4425137
    [No Abstract]   [Full Text] [Related]  

  • 10. Mescaline: no tolerance to excitatory effects.
    Bridger WH; Mandel IJ; Stoff DM
    Biol Psychiatry; 1973 Oct; 7(2):129-38. PubMed ID: 4748845
    [No Abstract]   [Full Text] [Related]  

  • 11. Tolerance and cross-tolerance to mescaline and amphetamine as a function of central and peripheral administration.
    Sparber SB; Tilson HA
    Psychopharmacologia; 1972; 23(3):220-30. PubMed ID: 5067530
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of cannabidiol and delta-9-tetrahydrocannabinol on operant behavior.
    Davis WM; Borgen LA
    Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):453-62. PubMed ID: 4445565
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of norcocaine and some norcocaine derivatives on schedule-controlled behavior of pigeons and squirrel monkeys.
    Spealman RD; Goldberg SR; Kelleher RT; Morse WH; Goldberg DM; Hakansson CG; Nieforth KA; Lazer ES
    J Pharmacol Exp Ther; 1979 Aug; 210(2):196-205. PubMed ID: 110921
    [No Abstract]   [Full Text] [Related]  

  • 14. Delta9-tetrahydrocannabinol and 11-hydroxy-delta9-tetrahydrocannabinol: behavioral effects and tolerance development.
    Kosersky DS; McMillan DE; Harris LS
    J Pharmacol Exp Ther; 1974 Apr; 189(1):61-5. PubMed ID: 4823300
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of cross-tolerance in rats among (-)delta9-trans-tetrahydrocannabinol(delta9-THC), cannabis extract, mescaline and lysergic acid diethylamide (LSD-25).
    Teresa M; Silva A; Carlini EA; Claussen U; Korte F
    Psychopharmacologia; 1968; 13(4):332-40. PubMed ID: 5722169
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of amphetamine on choice behavior of pigeons.
    Todorov JC; Gorayeb SR; Corréa DL; Graeff FG
    Psychopharmacologia; 1972; 26(4):395-400. PubMed ID: 4638203
    [No Abstract]   [Full Text] [Related]  

  • 17. Differences in tolerance to mescaline produced by peripheral and direct central administration.
    Tilson HA; Sparber SB
    Psychopharmacologia; 1971; 19(4):313-23. PubMed ID: 5109405
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention by naltrexone of tolerance to the rate-decreasing effects of morphine on schedule-controlled responding in the pigeon.
    Smith JB
    Psychopharmacology (Berl); 1979 May; 63(1):49-54. PubMed ID: 112621
    [No Abstract]   [Full Text] [Related]  

  • 19. Tolerance to the behavioral effects of marihuana in chimpanzees.
    Ferraro DP; Grisham MG
    Physiol Behav; 1972 Jul; 9(1):49-54. PubMed ID: 5080156
    [No Abstract]   [Full Text] [Related]  

  • 20. Some effects of local anesthetics on schedule-controlled behavior.
    McMillan DE; Dearstyne MR; Engstrom TG
    Pharmacol Ther Dent; 1975; 2(1):57-64. PubMed ID: 1054859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.